05 Mar Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its caused coronavirus disease 2019 (COVID-19) has been reported in China since December 2019.
Sorry, the comment form is closed at this time.